PRF1 and tuberculosis: In contrast to the parental protein Granulysin, it does not require the support of granzymes and perforin to inhibit the growth of intracellular Mtb. Our results pave the way for designing Gran1-containing nanoparticles, such as liposomes or mesoporous nanoparticles, which combine AMPs with conventional anti-tuberculosis compounds.